Cargando…

Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study

Detalles Bibliográficos
Autores principales: Manz, Kirsi, Bahr, Jeanette, Ittermann, Till, Döhner, Konstanze, Koschmieder, Steffen, Brümmendorf, Tim H., Griesshammer, Martin, Nauck, Matthias, Völzke, Henry, Heidel, Florian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400416/
https://www.ncbi.nlm.nih.gov/pubmed/37353711
http://dx.doi.org/10.1038/s41375-023-01943-8
_version_ 1785084440882446336
author Manz, Kirsi
Bahr, Jeanette
Ittermann, Till
Döhner, Konstanze
Koschmieder, Steffen
Brümmendorf, Tim H.
Griesshammer, Martin
Nauck, Matthias
Völzke, Henry
Heidel, Florian H.
author_facet Manz, Kirsi
Bahr, Jeanette
Ittermann, Till
Döhner, Konstanze
Koschmieder, Steffen
Brümmendorf, Tim H.
Griesshammer, Martin
Nauck, Matthias
Völzke, Henry
Heidel, Florian H.
author_sort Manz, Kirsi
collection PubMed
description
format Online
Article
Text
id pubmed-10400416
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104004162023-08-05 Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study Manz, Kirsi Bahr, Jeanette Ittermann, Till Döhner, Konstanze Koschmieder, Steffen Brümmendorf, Tim H. Griesshammer, Martin Nauck, Matthias Völzke, Henry Heidel, Florian H. Leukemia Letter Nature Publishing Group UK 2023-06-23 2023 /pmc/articles/PMC10400416/ /pubmed/37353711 http://dx.doi.org/10.1038/s41375-023-01943-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Manz, Kirsi
Bahr, Jeanette
Ittermann, Till
Döhner, Konstanze
Koschmieder, Steffen
Brümmendorf, Tim H.
Griesshammer, Martin
Nauck, Matthias
Völzke, Henry
Heidel, Florian H.
Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
title Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
title_full Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
title_fullStr Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
title_full_unstemmed Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
title_short Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
title_sort validation of myeloproliferative neoplasms associated risk factor rdw as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the ship-study
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400416/
https://www.ncbi.nlm.nih.gov/pubmed/37353711
http://dx.doi.org/10.1038/s41375-023-01943-8
work_keys_str_mv AT manzkirsi validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT bahrjeanette validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT ittermanntill validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT dohnerkonstanze validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT koschmiedersteffen validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT brummendorftimh validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT griesshammermartin validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT nauckmatthias validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT volzkehenry validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy
AT heidelflorianh validationofmyeloproliferativeneoplasmsassociatedriskfactorrdwaspredictorofthromboemboliccomplicationsinhealthyindividualsanalysison6849participantsoftheshipstudy